Investors Capital Advisory Services’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Investors Capital Advisory Services’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-7,067	Closed	-$321K	–	769
2015 Q2	$321K	Hold	7,067	–	–	0.06%	450
2015 Q1	$268K	Hold	7,067	–	–	0.05%	502
2014 Q4	$200K	Buy	+7,067	New	+$196K	0.04%	592

Other funds holding PTLA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Investors Capital Advisory Services's PTLA Position: Q3 2015 in Review

Investors Capital Advisory Services sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2015, closing a stake of 7,067 shares — an estimated $321K sold.

Investors Capital Advisory Services first reported a position in PTLA in Q4 2014 and held it in 3 quarters. The position peaked at $321K in Q2 2015. 171 funds tracked by Wall St. Rank hold PTLA as of Q3 2015.

Investors Capital Advisory Services reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Investors Capital Advisory Services sold 7,067 Portola Pharmaceuticals, Inc. shares in Q3 2015, an estimated $321K.
Investors Capital Advisory Services first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 3 quarters.
Investors Capital Advisory Services's Portola Pharmaceuticals, Inc. position peaked at $321K in Q2 2015.
171 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2015.

Based on Investors Capital Advisory Services's 13F filing for Q3 2015, filed 17 Nov 2015.